BIB icon

ProShares Ultra NASDAQ Biotechnology

27 hedge funds and large institutions have $19.7M invested in ProShares Ultra NASDAQ Biotechnology in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

25% less call options, than puts

Call options by funds: $8.44M | Put options by funds: $11.2M

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

Holders
27
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8.44M
Puts
$11.2M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$8.54M
2
$2.6M
3
$1.88M
4
$1.8M
5
$902K
6
$798K
7
$690K
8
$491K
9
$362K
10
$313K
11
$294K
12
$218K
13
$173K
14
$119K
15
$109K
16
$108K
17
$67K
18
$58.4K
19
$36K
20
$22K
21
$19K
22
$18K
23
$15K
24
$15K
25
$13K